Drugs / GSK2392019A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01160172 | Jul 2010 → Aug 2012 | staphylococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2392019A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160172 ↗ |
| Modality | Vaccine | “Staphylococcal investigational vaccine GSK2392019A” NCT01160172 ↗ |